Back
Nektar Therapeutics Stock Price Chart
Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
30
NKTR
Nektar Therapeutics
Last Price:
$0.64
Seasonality Move:
-4.36%
7 Day Trial
ALL ACCESS PASS
$
7
The Future of Housing Is Being Built Now
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing selling pressure, which indicates risk of future bearish movement.
Nektar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.69 | Sell |
| 20-day SMA: | 0.7 | Sell |
| 50-day SMA: | 0.7 | Sell |
| 200-day SMA: | 1 | Sell |
| 8-day EMA: | 0.67 | Sell |
| 20-day EMA: | 0.68 | Sell |
| 50-day EMA: | 0.71 | Sell |
| 200-day EMA: | 0.92 | Sell |
Nektar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 43.57 | Sell |
| Chaikin Money Flow: | -1490210 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.63 - 0.75) | Sell |
| Bollinger Bands (100): | (0.65 - 0.95) | Sell |
Nektar Therapeutics Technical Analysis
| May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Nektar Therapeutics Stock
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.63 while NKTR 8-day simple moving average is 0.69, which is a Sell signal.
-
The stock price of NKTR is 0.63 while Nektar Therapeutics 20-day SMA is 0.70, which makes it a Sell.
-
Nektar Therapeutics 50-day simple moving average is 0.70 while NKTR share price is 0.63, making it a Sell technically.
-
NKTR stock price is 0.63 and Nektar Therapeutics 200-day simple moving average is 1.00, creating a Sell signal.
NKTR Technical Analysis vs Fundamental Analysis
Sell
30
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $0.63. The Score for NKTR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Nektar Therapeutics Stock Info
Market Cap:
117.7M
Price in USD:
0.63
Share Volume:
2.4M
Nektar Therapeutics 52-Week Range
52-Week High:
1.75
52-Week Low:
0.43
Sell
30
Nektar Therapeutics (NKTR)
is a Sell
Nektar Therapeutics Share Price Forecast
-
What is the Nektar Therapeutics stock price today?The Nektar Therapeutics stock price is 0.63 USD today.
-
Will NKTR stock go up or go down?Nektar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nektar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nektar Therapeutics is overvalued.
Is Nektar Therapeutics Stock a Buy?
-
Nektar Therapeutics share price is 0.63 while NKTR 8-day exponential moving average is 0.67, which is a Sell signal.
-
The stock price of NKTR is 0.63 while Nektar Therapeutics 20-day EMA is 0.68, which makes it a Sell.
-
Nektar Therapeutics 50-day exponential moving average is 0.71 while NKTR share price is 0.63, making it a Sell technically.
-
NKTR stock price is 0.63 and Nektar Therapeutics 200-day simple moving average is 0.92, creating a Sell signal.
Fundamental Analysis of Nektar Therapeutics
Is Nektar Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.07 per share.
Technical Analysis of Nektar Therapeutics
Should I short Nektar Therapeutics stock?
-
NKTR Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Nektar Therapeutics is a Sell
-
Nektar Therapeutics Relative Strength Index (RSI) is 43.57, which suggest Nektar Therapeutics is oversold
-
The Bollinger Bands (25) for Nektar Therapeutics is (0.63 - 0.75), which suggest Nektar Therapeutics is a Sell
-
The Bollinger Bands (100) for Nektar Therapeutics is (0.65 - 0.95), which suggest Nektar Therapeutics is a Sell
* Nektar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.